Recently, hydralazine combined with isosorbide dinitrate has been reported
to reduce cardiovascular mortality more than conventional
therapy in African Americans with severe heart failure
67
and
historically more than the same therapy in Caucasian Americans,
68
although the factors contributing to thisethnic difference have not been defined clearly.